Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oil-in-water (O/W) emulsion adjuvants are vaccine components designed to enhance the immune response to co-administered antigens. These emulsions consist of tiny droplets of oil (commonly squalene) dispersed in water, stabilized by surfactants. They act primarily by creating a local inflammatory environment at the injection site, which recruits antigen-presenting cells (APCs). The adjuvant effect is not solely attributable to any single component but rather the emulsion structure itself. MF59 does not activate Toll-like receptors directly but requires MyD88 signaling for its activity through an alternative pathway. O/W emulsions induce both humoral and cellular immune responses. Squalene-based O/W emulsions like MF59 have been safely used in pandemic influenza vaccines since 2009 and continue to be included in seasonal flu shots as well as under investigation for COVID-19 vaccines.
Recruitment/activation of APCs; enhanced antigen uptake; induction of local inflammation; MyD88-dependent signaling; promotes both humoral/cellular immunity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Activation via Oil-in-Water Emulsion Adjuvant (O/W Emulsion Adjuvant).